Recombinant human follicle-stimulating hormone (r-hFSH) plus recombinant luteinizing hormone versus r-hFSH alone for ovarian stimulation during assisted reproductive technology: systematic review and meta-analysis-Reference-Cited by-同舟云学术

Recombinant human follicle-stimulating hormone (r-hFSH) plus recombinant luteinizing hormone versus r-hFSH alone for ovarian stimulation during assisted reproductive technology: systematic review and meta-analysis

Published:2014 Issue:1 Volume:12 Page:17
ISSN:1477-7827
Container-title:Reproductive Biology and Endocrinology
language:en
Short-container-title:Reprod Biol Endocrinol

Author:

Lehert Philippe,Kolibianakis Efstratios M,Venetis Christos A,Schertz Joan,Saunders Helen,Arriagada Pablo,Copt Samuel,Tarlatzis Basil

Publisher

Springer Science and Business Media LLC

Subject

Developmental Biology,Endocrinology,Reproductive Medicine,Obstetrics and Gynaecology

Reference49 articles.

1. Does exogenous LH in ovarian stimulation improve assisted reproduction success? An appraisal of the literature

2. Understanding the role of LH: myths and facts

3. Seven-day administration of the gonadotropin-releasing hormone antagonist Cetrorelix in normal cycling women

4. LH concentrations do not correlate with pregnancy in rFSH/GnRH antagonist cycles

5. Exogenous luteinizing hormone in controlled ovarian hyperstimulation for assisted reproduction techniques

Cited by 106 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assisted Reproductive Technology Outcomes in Women with Normal Ovarian Response Receiving Recombinant Luteinizing Hormone/Human Menopausal Gonadotropin: An Observational Study;International Journal of Women's Health;2024-06

2. Gonadotropins in assisted reproductive technology programs: A review;Gynecology;2024-05-09

3. Subtle perturbations of ovarian steroidogenesis in patients classified as Poseidon Group 3. Which consequences for therapeutic strategy?;Frontiers in Endocrinology;2024-02-07

4. The mild stimulation in vitro fertilization protocol;Handbook of Current and Novel Protocols for the Treatment of Infertility;2024

5. Effectiveness of recombinant human follicle-stimulating hormone (r-hFSH):recombinant human luteinizing hormone versus r-hFSH alone in assisted reproductive technology treatment cycles among women aged 35–40 years: a German database study;Reproductive BioMedicine Online;2023-11